Bionomics’ Initial Public Offering

Latham & Watkins represented Bionomics in the offering.Bionomics Limited, a clinical-stage biopharmaceutical company, has announced the pricing of its initial public offering in the United States of…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now